AstraZeneca Pharmaceuticals LP Products: Prescription Medications Section

Page 1 of 13 1 2 3 4 5 … 10 … » Last Page »

ACCOLATE (Zafirlukast)

ACCOLATE is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. CONTRAINDICATIONS: ACCOLATE is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive…

AstraZeneca Pharmaceuticals LP15 November 2013

ARIMIDEX (Anastrozole)

ARIMIDEX is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer (1.1) First-line treatment of…

AstraZeneca Pharmaceuticals LP2 May 2014

ATACAND (Candesartan Cilexetil)

ATACAND is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension in adults and children 1 to < 17 years of age, to lower blood pressure. Lowering blood…

AstraZeneca Pharmaceuticals LP5 July 2016

ATACAND HCT (Candesartan Cilexetil and Hydrochlorothiazide)

ATACAND HCT is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily…

AstraZeneca Pharmaceuticals LP5 July 2016

BEVESPI AEROSPHERE (Glycopyrrolate and Formoterol Fumarate)

BEVESPI AEROSPHERE is a combination of glycopyrrolate and formoterol fumarate indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD),…

AstraZeneca Pharmaceuticals LP29 May 2019

Page 1 of 13 1 2 3 4 5 … 10 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.